SWKS Surges 19% on iPhone Duo Hype: Is the LULU Pain Trade Next?

Let's talk about the week's real earnings story, because it is not Oracle (already covered, you're welcome) and it is not Adobe (ditto). This week's social sentiment spotlight belongs to a semiconductor supplier, a yoga pants brand in crisis, and a Mediterranean bowl company that is somehow winning the GLP-1 era. Buckle up.

$SWKS was the week's biggest winner in the earnings-adjacent trade. Skyworks Solutions surged 19% to its highest level in over a year after Apple dropped the iPhone Duo and several other devices. As a key component supplier to Apple, Skyworks basically gets a revenue tailwind every time Tim Cook does a keynote. The Bloomberg Closing Bell roundup flagged SWKS as the standout mover, and retail sentiment on YouTube was overwhelmingly bullish, with traders treating it as a proxy bet on iPhone cycle demand. The bull case is simple: if Apple sells iPhones, Skyworks gets paid. The bear case is equally simple: it has basically zero pricing power and lives or dies by Cupertino's supply chain decisions. Still, a 19% single-day move on supplier halo is not nothing.

$LULU, meanwhile, is having the kind of week that makes you want to return your leggings for a full refund. Baimo initiated with an underperform rating, citing a stale product engine and intense competition in athleisure. The company also announced a new CEO, Heidi O'Neill, which sounds like good news until you realize the market read it as a distress signal. Former CEO Christine Day told CNBC the problems are fixable, but the consumer discretionary sector is on pace for its worst year since 2022, and LULU and Nike are the two worst performers in the group. Social sentiment around Lululemon is sour. Retail traders are not buying the turnaround narrative yet, and until the new CEO shows a product catalyst, this looks like a falling knife in expensive leggings.

$CAVA is the quiet overachiever in this earnings cycle. The CEO went on Investor's Business Daily's YouTube channel and made a genuinely compelling case: GLP-1 drug users gravitate toward Mediterranean food naturally, which means the obesity drug boom is actually a tailwind for CAVA's menu. The company posted 31% revenue growth and kept menu price increases below half the industry average, underpricing inflation by over 10%. That is a rare combination of volume growth and pricing discipline that most restaurant chains would kill for. Sentiment around CAVA on social is quietly building.

The macro backdrop makes all of this trickier: the VIX is at 17.84 and climbing, the 10-year Treasury yield nearly touched 5%, and a Fed rate hike is priced at roughly 90% probability for next week. Earnings beats in this environment get punished on balance sheet concerns (see: Oracle), and any miss will get absolutely torched. Retail traders know this, which is why the most-discussed earnings plays this week were all about companies with clean stories: hardware suppliers with iPhone tailwinds, or restaurant brands with structural demand drivers. The ones with messy narratives, LULU chief among them, are getting no benefit of the doubt.

Yoga pants, rice bowls, and radio frequency chips: somehow this is what earnings season looks like in September 2026, and honestly it tracks.